After adjusted for tumor grade and progesterone receptor status, patients harboring GSTT1 null genotype had a lower risk of death compared with patients with GSTT1 present genotype (HR = 0.630 and 0.612) nevertheless, there was not statistically significant difference (P = 0.152 and 0.143). The gene discussed is PGR; the disease is neoplasm.